These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16870521)

  • 1. Development of vaccines against influenza H5.
    Stephenson I; Gust I; Pervikov Y; Kieny MP
    Lancet Infect Dis; 2006 Aug; 6(8):458-60. PubMed ID: 16870521
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines against avian influenza--a race against time.
    Poland GA
    N Engl J Med; 2006 Mar; 354(13):1411-3. PubMed ID: 16571885
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
    Rauw F; Palya V; Van Borm S; Welby S; Tatar-Kis T; Gardin Y; Dorsey KM; Aly MM; Hassan MK; Soliman MA; Lambrecht B; van den Berg T
    Vaccine; 2011 Mar; 29(14):2590-600. PubMed ID: 21292007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine decisions loom for new flu strain.
    Butler D
    Nature; 2009 May; 459(7244):144-5. PubMed ID: 19444174
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccines in development against avian influenza.
    Cox MM
    Minerva Med; 2007 Apr; 98(2):145-53. PubMed ID: 17519856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.
    Goji NA; Nolan C; Hill H; Wolff M; Noah DL; Williams TB; Rowe T; Treanor JJ
    J Infect Dis; 2008 Sep; 198(5):635-41. PubMed ID: 18694338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The threat of avian influenza A (H5N1). Part IV: Development of vaccines.
    Cinatl J; Michaelis M; Doerr HW
    Med Microbiol Immunol; 2007 Dec; 196(4):213-25. PubMed ID: 17541633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets.
    Gustin KM; Maines TR; Belser JA; van Hoeven N; Lu X; Dong L; Isakova-Sivak I; Chen LM; Voeten JT; Heldens JG; van den Bosch H; Cox NJ; Tumpey TM; Klimov AI; Rudenko L; Donis RO; Katz JM
    J Infect Dis; 2011 Nov; 204(10):1491-9. PubMed ID: 21957153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
    J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inactivated subvirion influenza A (H5N1) vaccine.
    Johansson BE; Brett IC
    N Engl J Med; 2006 Jun; 354(25):2724-5; author reply 2724-5. PubMed ID: 16790710
    [No Abstract]   [Full Text] [Related]  

  • 14. Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI.
    Steensels M; Bublot M; Van Borm S; De Vriese J; Lambrecht B; Richard-Mazet A; Chanavat-Bizzini S; Duboeuf M; Le Gros FX; van den Berg T
    Vaccine; 2009 Jan; 27(5):646-54. PubMed ID: 19056442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of vaccines against influenza A virus (H5N1).
    Li WC; Huang YC
    Chang Gung Med J; 2007; 30(4):294-304. PubMed ID: 17939259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.
    Wu J; Fang HH; Chen JT; Zhou JC; Feng ZJ; Li CG; Qiu YZ; Liu Y; Lu M; Liu LY; Dong SS; Gao Q; Zhang XM; Wang N; Yin WD; Dong XP
    Clin Infect Dis; 2009 Apr; 48(8):1087-95. PubMed ID: 19281330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing vaccines for pandemic influenza.
    Horimoto T; Kawaoka Y
    Curr Top Microbiol Immunol; 2009; 333():165-76. PubMed ID: 19768405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avian influenza vaccines: what's all the flap?
    Sambhara S; Poland GA
    Lancet; 2006 May; 367(9523):1636-8. PubMed ID: 16714169
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.
    Treanor JJ; Campbell JD; Zangwill KM; Rowe T; Wolff M
    N Engl J Med; 2006 Mar; 354(13):1343-51. PubMed ID: 16571878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza A (H5N1) pandemic prototype vaccine Fluval.
    Vajo Z
    Expert Rev Vaccines; 2009 May; 8(5):619-24. PubMed ID: 19397418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.